BCG Revaccination in Children and Adolescents

PHASE3SuspendedINTERVENTIONAL
Enrollment

9,200

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Tuberculosis InfectionTuberculosis
Interventions
BIOLOGICAL

BCG vaccine

0.1ml BCg vaccine to be given intradermally

DRUG

Oral Chemoprophylaxis

Oral chemoprophylaxis will be standard of care - either 6 months of Isoniazid or 3 months of weekly Isoniazid and Rifapentine

Trial Locations (1)

600031

Dr Aishwarya Venkataraman, Chennai

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Institute of Child Health, Chennai

UNKNOWN

collaborator

All India Institute of Medical Sciences

OTHER

collaborator

The Grant Medical College & Sir J.J. Group of Hospitals

OTHER_GOV

collaborator

All India Institute of Medical Sciences, Bhubaneswar

OTHER

collaborator

Rajendra Institute of Medical Sciences, Ranchi

UNKNOWN

collaborator

National Institute of Tuberculosis and Respiratory Diseases, New Delhi

UNKNOWN

collaborator

Rajiv Gandhi Hospital, Chennai

UNKNOWN

collaborator

Madurai Medical College

OTHER

collaborator

Government Vellore Medical College, Vellore

UNKNOWN

lead

Tuberculosis Research Centre, India

OTHER_GOV

NCT05330884 - BCG Revaccination in Children and Adolescents | Biotech Hunter | Biotech Hunter